scientifyRESEARCH
research funding database

RESEARCH FUNDING

This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

Pilot Award – acral melanoma (worldwide)

Share this post

funding consultation boking
Logo of scientifyRESEARCH + logo of Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Pilot Award – acral melanoma funded by the Melanoma Research Alliance (MRA) supports established researchers who have potentially transformative ideas for acral melanoma research, do not have extensive preliminary data but articulate a clear hypothesis and translational goals. Acral melanoma accounts for approximately 2-3% of all melanomas and affects people of all races and ethnicities but does disproportionately impact people of color. Priority will be given to proposals that focus on the following areas:

  • Understanding how to effectively target NF1 loss, CRKL and GAB2 amplification, and/or TERT alterations in acral melanoma;
  • Characterizing the anti-tumor immune response to acral melanoma, including identification of prognostic indicators of response/non-response, and/or development of resistance to checkpoint immunotherapy;
  • Identifying and developing novel immune, targeted and combination approaches for preclinical testing in acral melanoma models.

Applicants should be at least 5 years beyond their first independent academic appointment. Applications are open to US and international applicants. The Award provides 50,000 USD/year for 2 years. Indirect costs are not allowed, applicants may include fringe benefits for salaries in the proposal.

Full applications close on November 3, 2023.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts

Logo3